In the case of dMMR/MSI CRC with MLH1 loss and BRAF wild type status, MLH1 promoter methylation is determined and a MLH1 promoter hypermethylation signs the sporadic trait of the tumor. The gene discussed is BRAF; the disease is colorectal carcinoma.